US STD diagnostics market is growing at a CAGR of around 8.1% during the forecast period. The major aspects that are making considerable contributing towards its high market share include the fact that the country emphasizes more towards increasing the efficiency with the effectiveness of the treatment of various diseases including STDs. Further, the rapidly developed healthcare infrastructure and significant government healthcare spending are promoting R&D of such advanced technology across the country thereby promoting the growth of the US STD diagnostics market.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/us-sexually-transmitted-disease-market
According to the Research America, the US had spent $182.3 billion in R&D of medical and healthcare and several investments were made by the foundations, industries, Federal agencies and others. The federal agencies had invested more than $35.9 million along with National Institute of Health that comprises $29.6 billion share. There was several spending that the US healthcare and medical had received for research and development R&D activities.
Several research segments such as healthcare and medical researchers, federal government, academic and research institutes, non-research conducting grant giving entities, as well as state and local government in the US tend to invest heavily in the research of healthcare and medical drugs, medical devices which directly affects the growth of the US STD diagnostics market during the forecast period.
Abbott Laboratories, Inc., Becton, Dickinson and Co., Danaher Corp., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific, Inc. among others are some of the key players operating in the US STD diagnostics market. The STD diagnostics key players are adopting various strategies such as new product launches and approvals, merger and acquisition, partnerships and collaborations, and many others in order to thrive in a competitive environment.
US STD Diagnostics Market Segmentation
By Disease Type
- Chlamydia
- Syphilis
- Gonorrhea
- Herpes Simplex Virus (HSV)
- Human Papilloma Virus (HPV)
- Human Immunodeficiency Virus (HIV)
- Others
By Product
- Laboratory Testing Devices
- Point-of-Care (POC) Testing Devices
By End-user
- Hospitals and Clinics
- Diagnostic Centers
- Homecare
A full report of US Sexually Transmitted Diseases (STD) Diagnostics Market available @ https://www.omrglobal.com/industry-reports/us-sexually-transmitted-disease-market
Company Profiles
- Abbott Laboratories, Inc.
- AbbVie Inc.
- Becton, Dickinson and Co.
- Biocartis NV
- Bio-Rad Laboratories, Inc.
- Danaher Corp.
- Eli Lilly and Co.
- Hoffmann-La Roche Ltd.
- Merck KGaA
- Thermo Fisher Scientific, Inc.
